Tarsus Pharmaceuticals, Inc. (TARS)
$72.81+0.15%Close
BUYRECOVERY · day 21
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $3.1B
- Avg volume
- 885.4K
- Beta
- 0.51
- P/E (TTM)
- -66.80
- Short % float
- 14.90%
- Days to cover
- 6.6
- SI change
- +4.0%
- 1W
- +3.12%
- 1M
- +24.12%
- 3M
- +16.95%
- YTD
- -9.86%
- vs SPY 1W
- +4.31%
- vs SPY 1M
- +20.80%
- vs SPY 3M
- +14.55%
- vs SPY YTD
- -21.61%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- HOOKSELLHOOKIPA Pharma Inc.BULLQ -18$1.15+0.00%
- PBMBUYPsyence Biomedical Ltd.RECOVERYQ -30$4.22-2.54%
- NEOBUYNeoGenomics, Inc.BULLQ 25$16.41-3.36%
- OMDABUYOmada HealthBULLQ 6$24.08+0.80%
- NVAXBUYNovavax, Inc.RECOVERYQ 9$8.86-0.89%
- KURABUYKura Oncology, Inc.RECOVERYQ 13$12.40+4.29%
- GLMDSELLGalmed Pharmaceuticals Ltd.CRISISQ -13$4.05-6.03%
- GYREBUYGyre Therapeutics, Inc.RECOVERYQ -2$6.44-6.80%
- MNDRSELLMobile-health Network Solutions Class A Ordinary SharesCRISISQ -29$1.65-1.20%
- CNCBUYCentene CorporationBULLQ 15$65.65+0.97%
- MDCXSELLMedicus Pharma Ltd. Common StockCRISISQ -35$0.26-3.70%
- INBXBUYInhibrx Biosciences, Inc.RECOVERYQ 33$104.94+1.26%
Industry peers
FMP comparable companies · ranked by market cap
- SRRKBUYScholar Rock Holding Corporation$7.0BRECOVERYQ 25$58.20+3.01%
- CGONBUYCG Oncology Inc.$6.9BBULLQ 32$78.23-1.98%
- TVTXBUYTravere Therapeutics, Inc.$6.1BBULLQ 34$65.22-0.75%
- CELCSELLCelcuity Inc.$4.4BRECOVERYQ 29$90.79-2.93%
- ADPTSELLAdaptive Biotechnologies Corporation$4.1BRECOVERYQ 6$25.55-1.69%
- LEGNBUYLegend Biotech Corporation$3.9BRECOVERYQ 4$20.94-4.03%
- IRONBUYDisc Medicine, Inc.$3.1BRECOVERYQ 4$80.94+1.42%
- ARQTSELLArcutis Biotherapeutics, Inc.$3.1BRECOVERYQ 10$24.78-1.20%
- ZLABBUYZai Lab Limited$2.9BRECOVERYQ 9$25.64-1.42%
- AAPGSELLAscentage Pharma Group International$1.6BCRISISQ 8$16.71-1.71%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 14
- VALUE
- 3
- GROWTH
- 40
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-8.1%
REV YoY-
ROE-13.5%
EPS YoY-
ROA-7.6%
GROSS91
OP-8
NET-8
[VALUATION]
P/E TTM-66.80
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B9.11
P/FCF-
EV/EBITDA-85.66
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E25.57
ALTMAN Z-
CURR RATIO3.20
ND/EBITDA-
BETA0.51
